SCHEMBL1491975

SCHEMBL1491975

[C]#CC(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)F

nearest known ligand 0.38

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
LMNA P02545 1/20 0.38
THRB P10828 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5574073 1.00 LMNA (0.38) LMNATHRB
SCHEMBL15351894 1.00 LMNA (0.38) LMNATHRB
SCHEMBL15352393 1.00 LMNA (0.38) LMNATHRB
SCHEMBL7458180 1.00 LMNA (0.38) LMNATHRB
SCHEMBL15351871 1.00 LMNA (0.38) LMNATHRB
SCHEMBL1491995 0.97 LMNA (0.33) LMNA
SCHEMBL5574014 0.87
SCHEMBL672220 0.73 LMNA (0.42) LMNATHRB
SCHEMBL1492033 0.72
SCHEMBL6449827 0.71 LMNA (0.53) LMNATHRB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 30 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3059235-B1 TETRAZOLINONE DERIVATIVES AND THEIR USE FOR CONTROLLING PESTS SUMITOMO CHEMICAL CO (JP) 2020-10-28 EP disclosed
US-20180331339-A1 POROUS MEMBRANE SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2018-11-15 US disclosed
US-10085450-B2 Tetrazolinone compound and use thereof SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2018-10-02 US disclosed
US-10062888-B2 Porous membrane SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2018-08-28 US disclosed
CN-105636957-B Terazololine-one compound and application thereof 住友化学株式会社 2018-05-11 CN disclosed
US-9837650-B2 Porous membrane SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2017-12-05 US disclosed
CN-104271571-B Tetrazolinone compound and use thereof 住友化学株式会社 2017-07-07 CN disclosed
EP-2841433-B1 TETRAZOLINONE COMPOUNDS AND ITS USE SUMITOMO CHEMICAL CO (JP) 2017-06-21 EP disclosed
US-20170162846-A1 POROUS MEMBRANE Sumitomo Checical Company, Limited (JP) 2017-06-08 US disclosed
US-20170149037-A1 POROUS MEMBRANE SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2017-05-25 US disclosed
US-20110073854-A1 POLYMER COMPOUND AND ORGANIC TRANSISTOR USING THE SAME SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2011-03-31 US disclosed
EP-2289965-A1 POLYMER COMPOUND AND ORGANIC TRANSISTOR USING THE POLYMER COMPOUND Sumitomo Chemical Company, Limited (JP) 2011-03-02 EP disclosed
US-7662478-B2 Polymer and polymer light-emitting device using the same SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2010-02-16 US disclosed
EP-1318163-B1 New polymer and polymer light-emitting device using the same SUMITOMO CHEMICAL CO (JP) 2010-01-27 EP disclosed
EP-2067807-A1 New polymer and polymer light-emitting device using the same Sumitomo Chemical Company, Limited (JP) 2009-06-10 EP disclosed
EP-2067808-A1 New polymer and polymer light-emitting device using the same Sumitomo Chemical Company, Limited (JP) 2009-06-10 EP disclosed
US-20080103278-A1 NEW POLYMER AND POLYMER LIGHT-EMITTING DEVICE USING THE SAME SUMITOMO CHEMICAL COMPANY, LIMITED 2008-05-01 US disclosed
US-20050042195-A1 New polymer and polymer light-emitting device using the same SUMITOMO CHEMICAL COMPANY, LIMITED 2005-02-24 US disclosed
US-20030168656-A1 New polymer and polymer light-emitting device using the same SUMITOMO CHEMICAL COMPANY, LIMITED 2003-09-11 US disclosed
EP-1318163-A1 New polymer and polymer light-emitting device using the same SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2003-06-11 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110073854-A1 POLYMER COMPOUND AND ORGANIC TRANSISTOR USING THE SAME TERT, NOXO1, TERB1 LMNA 2365/4885THRB 1039/4885
US-20080103278-A1 NEW POLYMER AND POLYMER LIGHT-EMITTING DEVICE USING THE SAME CRY1, ARCN1, CORO1A LMNA 679/4885THRB 2630/4885
US-10085450-B2 Tetrazolinone compound and use thereof ROS1, TCOF1, RPS20 LMNA 4241/4885THRB 281/4885
US-20050042195-A1 New polymer and polymer light-emitting device using the same CRY1, ARCN1, CORO1A LMNA 679/4885THRB 2630/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.